Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC878726584;26585;26586 chr2:178714415;178714414;178714413chr2:179579142;179579141;179579140
N2AB847025633;25634;25635 chr2:178714415;178714414;178714413chr2:179579142;179579141;179579140
N2A754322852;22853;22854 chr2:178714415;178714414;178714413chr2:179579142;179579141;179579140
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: Y
  • RefSeq wild type transcript codon: TAT
  • RefSeq wild type template codon: ATA
  • Domain: Ig-73
  • Domain position: 52
  • Structural Position: 127
  • Q(SASA): 0.2777
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
Y/C rs1365431842 -0.867 0.993 N 0.661 0.537 0.692462537607 gnomAD-2.1.1 8.07E-06 None None None None N None 0 0 None 0 1.11346E-04 None 0 None 0 0 0
Y/C rs1365431842 -0.867 0.993 N 0.661 0.537 0.692462537607 gnomAD-4.0.0 2.05272E-06 None None None None N None 0 0 None 0 7.55744E-05 None 0 0 0 0 0
Y/F None None None N 0.281 0.142 0.289847578895 gnomAD-4.0.0 6.8424E-07 None None None None N None 0 0 None 0 0 None 0 0 8.99497E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
Y/A 0.4075 ambiguous 0.5384 ambiguous -1.939 Destabilizing 0.706 D 0.637 neutral None None None None N
Y/C 0.1294 likely_benign 0.1803 benign -0.891 Destabilizing 0.993 D 0.661 neutral N 0.520459716 None None N
Y/D 0.2657 likely_benign 0.4106 ambiguous -0.143 Destabilizing 0.864 D 0.684 prob.neutral N 0.496822052 None None N
Y/E 0.5988 likely_pathogenic 0.7409 pathogenic -0.056 Destabilizing 0.894 D 0.686 prob.neutral None None None None N
Y/F 0.1005 likely_benign 0.1035 benign -0.726 Destabilizing None N 0.281 neutral N 0.430567108 None None N
Y/G 0.3853 ambiguous 0.5159 ambiguous -2.258 Highly Destabilizing 0.706 D 0.673 neutral None None None None N
Y/H 0.1312 likely_benign 0.1726 benign -0.762 Destabilizing 0.004 N 0.298 neutral N 0.485972726 None None N
Y/I 0.3901 ambiguous 0.4922 ambiguous -0.994 Destabilizing 0.045 N 0.608 neutral None None None None N
Y/K 0.5052 ambiguous 0.6314 pathogenic -0.923 Destabilizing 0.505 D 0.686 prob.neutral None None None None N
Y/L 0.3703 ambiguous 0.4426 ambiguous -0.994 Destabilizing 0.019 N 0.549 neutral None None None None N
Y/M 0.5971 likely_pathogenic 0.6761 pathogenic -0.79 Destabilizing 0.837 D 0.624 neutral None None None None N
Y/N 0.1655 likely_benign 0.2304 benign -1.231 Destabilizing 0.761 D 0.684 prob.neutral N 0.499464259 None None N
Y/P 0.7933 likely_pathogenic 0.8862 pathogenic -1.301 Destabilizing 0.981 D 0.685 prob.neutral None None None None N
Y/Q 0.3964 ambiguous 0.5206 ambiguous -1.1 Destabilizing 0.717 D 0.644 neutral None None None None N
Y/R 0.3155 likely_benign 0.4209 ambiguous -0.601 Destabilizing 0.778 D 0.692 prob.neutral None None None None N
Y/S 0.1558 likely_benign 0.2245 benign -1.837 Destabilizing 0.645 D 0.68 prob.neutral N 0.517319301 None None N
Y/T 0.319 likely_benign 0.4224 ambiguous -1.649 Destabilizing 0.945 D 0.684 prob.neutral None None None None N
Y/V 0.3147 likely_benign 0.3953 ambiguous -1.301 Destabilizing 0.706 D 0.549 neutral None None None None N
Y/W 0.3611 ambiguous 0.4102 ambiguous -0.378 Destabilizing 0.967 D 0.616 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.